SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-012330
Filing Date
2018-11-09
Accepted
2018-11-09 16:47:18
Documents
39
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT mnpr_10qq32018.htm 10-Q 719090
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit_31-1.htm EX-31.1 9978
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit_31-2.htm EX-31.2 9799
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit_32-1.htm EX-32.1 9380
  Complete submission text file 0001654954-18-012330.txt   2161583

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mono-20180930.xml EX-101.INS 346270
6 XBRL TAXONOMY EXTENSION SCHEMA mono-20180930.xsd EX-101.SCH 17915
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mono-20180930_cal.xml EX-101.CAL 26205
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mono-20180930_def.xml EX-101.DEF 26906
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mono-20180930_lab.xml EX-101.LAB 122886
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mono-20180930_pre.xml EX-101.PRE 96113
Mailing Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062
Business Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062 6143958936
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-55866 | Film No.: 181173709
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1